CC-1088 Therapy for Chronic Lymphocytic Leukemia: A Phase I/II Trial.

Trial Profile

CC-1088 Therapy for Chronic Lymphocytic Leukemia: A Phase I/II Trial.

Completed
Phase of Trial: Phase II

Latest Information Update: 21 Sep 2010

At a glance

  • Drugs CC 1088 (Primary)
  • Indications Chronic lymphocytic leukaemia
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 21 Sep 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Sep 2010 Actual end date (Jul 2005) added as reported by ClinicalTrials.gov.
    • 27 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top